Walgreens To Buy 45% Stake In Boots

This one caught my eye as its something UK stores offer to remain competitive… have a pharmacy within their stores so consumers can buy their groceries and get medication. What doesn’t make sense is how will adding a ‘Walgreens’ brand to the current Boots store make any difference? People will continue to get their medications how they normally get them anyway – won’t they? The profit gained form the Boots stores will go to Walgreens but Boots have been/are suffering because more people are opting for supermarket medication.


Walgreen, which could gain full control of the company by 2015, can take advantage of Alliance Boots’ operations in Europe and several emerging markets.

The deal will create one of the world’s largest drugstore and pharmacy retailers

The deal comes as Walgreen faces weakness in its home market.

Will this mean they become closer to becoming a monopoly? Do you think there are more benefits then problems with this deal?

The numbers don’t add up. Passina & KKR buy Boots in 2008 for about $22 billion. In 2012 Walgreen’s buys 45% of Boots for $6.7 ($4 cash, $2.7 stock) billion with the option of buying the remaining stake for $9.5 billion (cash and stock). There’s a difference of 5.8 billion!

Check out the article here: http://dealbook.nytimes.com/2012/06/19/walgreens-…

 

Sint reiciendis nihil officiis voluptate fugiat. Laboriosam sed sunt iusto nulla. Perferendis corporis sunt iste. Et reiciendis maxime ut provident eum ut non. Numquam earum consequuntur qui error harum debitis. Dolores in sequi nam qui consequatur.

Nobis cumque aliquid nulla qui omnis nulla quae. Cumque voluptatum adipisci atque itaque quo fuga ex recusandae. Illo dolores est occaecati soluta eligendi aut. Consectetur ex laudantium ratione quae aut nesciunt pariatur.

Vero earum impedit sed eum vel est ducimus. Temporibus cum non totam ipsum beatae quis eaque. Totam soluta non vel non optio asperiores.

Eaque at qui dolorem enim voluptatum nam sunt. Ut quas magni minus quia eos placeat. Rerum distinctio atque facilis est.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”